ConductScience.org, home

Paper10219843

Influence of cholestasis on absorption of ursodeoxycholic acid.

Sauer P and 5 others. Dig Dis Sci, 1999. Cited by 27 papers, by iCite.

Cite this record

ConductScience Library. Influence of cholestasis on absorption of ursodeoxycholic acid. Papers, record 10219843. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/10219843

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Influence of cholestasis on absorption of ursodeoxycholic acid.
PubMed
Journal
Dig Dis Sci
PubMed
Year
1999
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
27
iCite
Relative citation ratio, by iCite
0.88
iCite
Revised in PubMed
2026-10-16
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Sauer PP
2Benz CC
3Rudolph GG
4Klöters-Plachky PP
5Stremmel WW
6Stiehl AA

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Cholagogues and CholereticsMajor topic
CholestasisMajor topic
Pancreatic NeoplasmsMajor topic
Ursodeoxycholic AcidMajor topic
Administration, Oral
Aged
Bile Acids and Salts
Bilirubin
Drainage
Female
Humans
Intestinal Absorption
Male
Middle Aged

Source PubMed

Download CSV of topics

References37

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
1864325Analysis of metabolic profiles of bile acids in urine using a lipophilic anion exchanger and computerized gas-liquid chromatorgaphy-mass spectrometry.J Lipid Res1977https://conductscience.org/library/papers/864325PubMed
21505913Ursodeoxycholic acid for treatment of primary sclerosing cholangitis: a placebo-controlled trial.Hepatology1992https://conductscience.org/library/papers/1505913PubMed
32365199Asymptomatic primary sclerosing cholangitis treated with ursodeoxycholic acid.Gastroenterology1990https://conductscience.org/library/papers/2365199PubMed
41959845Changes in bile acid composition in patients with primary biliary cirrhosis induced by ursodeoxycholic acid administration.Hepatology1991https://conductscience.org/library/papers/1959845PubMed
51937390Ursodeoxycholic acid for the treatment of primary sclerosing cholangitis: a 30-month pilot study.Hepatology1991https://conductscience.org/library/papers/1937390PubMed
61537519Intestinal absorption of ursodeoxycholic acid in patients with extrahepatic biliary obstruction and bile drainage.Gastroenterology1992https://conductscience.org/library/papers/1537519PubMed
77557144Vesicle targeting to the apical domain regulates bile excretory function in isolated rat hepatocyte couplets.Gastroenterology1995https://conductscience.org/library/papers/7557144PubMed
82777202Effect of ursodeoxycholic acid on bile acid metabolism in primary biliary cirrhosis.Hepatology1989https://conductscience.org/library/papers/2777202PubMed
92295398Acute effects of ursodeoxycholic and chenodeoxycholic acid on the small intestinal absorption of bile acids.Gastroenterology1990https://conductscience.org/library/papers/2295398PubMed
108254052Tauroursodeoxycholic acid stimulates hepatocellular exocytosis and mobilizes extracellular Ca++ mechanisms defective in cholestasis.J Clin Invest1993https://conductscience.org/library/papers/8254052PubMed
111590390Regulatory volume decrease stimulates bile flow, bile acid excretion, and exocytosis in isolated perfused rat liver.Am J Physiol1992https://conductscience.org/library/papers/1590390PubMed
122401455Ursodeoxycholic acid-induced changes of plasma and urinary bile acids in patients with primary biliary cirrhosis.Hepatology1990https://conductscience.org/library/papers/2401455PubMed
137657280A randomized, double-blind, placebo-controlled trial of ursodeoxycholic acid in primary biliary cirrhosis.Hepatology1995https://conductscience.org/library/papers/7657280PubMed
141847897Regulation of bile acid synthesis.Hepatology1991https://conductscience.org/library/papers/1847897PubMed
158290601Regulation of activity and apical targeting of the Cl-/HCO3- exchanger in rat hepatocytes.Proc Natl Acad Sci U S A1994https://conductscience.org/library/papers/8290601PubMed
168175136The Canadian Multicenter Double-blind Randomized Controlled Trial of ursodeoxycholic acid in primary biliary cirrhosis.Hepatology1994https://conductscience.org/library/papers/8175136PubMed
178617445Adaptive response of the enterohepatic circulation of bile acids to extrahepatic cholestasis.Hepatology1996https://conductscience.org/library/papers/8617445PubMed
188201224Effect of ursodeoxycholic acid on liver and bile duct disease in primary sclerosing cholangitis. A 3-year pilot study with a placebo-controlled study period.J Hepatol1994https://conductscience.org/library/papers/8201224PubMed
198174890Ursodeoxycholic acid in the treatment of primary biliary cirrhosis.Gastroenterology1994https://conductscience.org/library/papers/8174890PubMed
206724256Differences in the effects of chenodeoxycholic and ursodeoxycholic acid on biliary lipid secretion and bile acid synthesis in patients with gallstones.Gastroenterology1984https://conductscience.org/library/papers/6724256PubMed

See all 37 referencesDownload CSV of references

Cited by10

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 27 citations.

PMIDTitleJournalYearIn PapersSource
42298049The longstanding issue of the benefit of ursodeoxycholic acid in primary sclerosing cholangitis: a long-term population-based study.J Gastroenterol2026https://conductscience.org/library/papers/42298049PubMed
36830173Diagnosis by Microbial Culture, Breath Tests and Urinary Excretion Tests, and Treatments of Small Intestinal Bacterial Overgrowth.Antibiotics (Basel)2023https://conductscience.org/library/papers/36830173PubMed
31671869Preclinical Evaluation of UDCA-Containing Oral Formulation in Mice for the Treatment of Wet Age-Related Macular Degeneration.Pharmaceutics2019https://conductscience.org/library/papers/31671869PubMed
20564380Bile acid changes after high-dose ursodeoxycholic acid treatment in primary sclerosing cholangitis: Relation to disease progression.Hepatology2010https://conductscience.org/library/papers/20564380PubMed
17391626Treatment of primary sclerosing cholangitis.Curr Treat Options Gastroenterol2007https://conductscience.org/library/papers/17391626PubMed
16773706Ursodeoxycholic acid treatment of vanishing bile duct syndromes.World J Gastroenterol2006https://conductscience.org/library/papers/16773706PubMed
16614977Effect of colitis and ileoanal pouch on biliary enrichment of ursodeoxycholic acid in primary sclerosing cholangitis.Dig Dis Sci2006https://conductscience.org/library/papers/16614977PubMed
16150853Adaptive regulation of the ileal apical sodium dependent bile acid transporter (ASBT) in patients with obstructive cholestasis.Gut2006https://conductscience.org/library/papers/16150853PubMed
15609388Primary sclerosing cholangitis: updates in diagnosis and therapy.World J Gastroenterol2005https://conductscience.org/library/papers/15609388PubMed
14735241[Primary sclerosing cholangitis].Internist (Berl)2004https://conductscience.org/library/papers/14735241PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/10219843

GET https://conductscience.org/api/papers/v1/10219843/references?page=2